Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection

Journal of Infectious Diseases

Volumn 178, Issue 5 SUPPL., 1998, Pages 1306-1316

  Loomis Price, Lawrence D ^a  

^a 3Henry M Jackson Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CORRELATION FUNCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS ISOLATION;

BIOSENSING TECHNIQUES; COHORT STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; IMMUNODOMINANT EPITOPES; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; RECEPTORS, CCR5;

EID: 0031724031     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314436     Document Type: Article

References (5)

1. Graham BS, Wright PF. Candidate AIDS vaccines. N Engl J Med 1995;333: 1331-9.
2. Birx DL, Davis D, Ruiz N. Results of a phase II double-blinded, multicenter, placebo-controlled HIV therapeutic vaccine trial [abstract Tu.A.275]. In: Program and abstracts: XI International Conference on AIDS (Vancouver, Canada). Vancouver: XI International Conference on AIDS Society, 1996: 222.
3. Redfield RR, Burke DS. HIV infection: the clinical picture. Sci Am 1988; 259:90-8.
4. Schnittman SM, Fauci AS. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update. Adv Intern Med 1994;39:305-55.
5. Lifson AR, Rutherford GW, Jaffe HW. The natural history of human immunodeficiency virus infection. J Infect Dis 1988;158:1360-7.